Literature DB >> 23613371

["DIabetes Versorgungs-Evaluation" (DIVE)--a national quality assurance initiative at physicians providing care for patients with diabetes].

T Danne1, M Kaltheuner, A Koch, S Ernst, W Rathmann, H-J Rüssmann, P Bramlage.   

Abstract

BACKGROUND: Due to the variety of affected organ systems, necessitating a multidisciplinary and interconnected approach in deciding on individual diagnostic and therapeutic strategies, a structured documentation of data for patients suffering from diabetes mellitus is steadily gaining importance. Towards this purpose, multiple quality initiatives (e. g. SWEET, QS-DPV, EUBIROD etc.) as well as several software systems (e. g. [DPV2] DIAMAX, DPV, EMIL, Qmax etc.) have been developed to capture patient-related data. This is further complicated by the necessity to exchange data with a large variety of doctor's office administration systems.
METHODS: To address this complex of issues, DiabetesDE in cooperation with several societies, doctor's associations and prospective end users launched a national register platform. DIVE (Diabetes Care Evaluation) is aimed at establishing a national diabetes register to centrally capture data from diabetes patients being treated by diabetology specialists in Germany, thus making them available for quality assurance and health services research.
RESULTS: Since September 2011, 142 so far participating doctors have documented data for 84,774 patients. Compared to patients treated by general practitioners, persons under specialist care show a more advanced clinical picture with substantial co-morbidity.
CONCLUSION: DIVE provides a national platform which will address essential fields of activity with regard to the development of a national diabetes strategy--epidemiology, diabetes registry, health care research, quality assurance--based on usual office administration systems, thus contributing to the improvement of care and treatment for patients suffering from diabetes. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23613371     DOI: 10.1055/s-0033-1343144

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  10 in total

1.  [Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE].

Authors:  Barbara Bohn; Peter Bramlage; Christian Wagner; Matthias Kaltheuner; Reinhard Welp; Stefan Sziegoleit; Artur Zimmermann; Hans Martin Reuter; Michael Hummel; Jörg Gloyer; Reinhard W Holl; Thomas Danne
Journal:  Wien Med Wochenschr       Date:  2017-08-21

2.  Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations - a registry-based analysis.

Authors:  Peter Bramlage; Stefanie Lanzinger; Sascha R Tittel; Eva Hess; Simon Fahrner; Christoph H J Heyer; Mathias Friebe; Ivo Buschmann; Thomas Danne; Jochen Seufert; Reinhard W Holl
Journal:  BMC Nephrol       Date:  2021-05-19       Impact factor: 2.388

3.  DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus.

Authors:  Gesine van Mark; Sascha R Tittel; Reinhard Welp; Jörg Gloyer; Stefan Sziegoleit; Ralf Barion; Peter M Jehle; Dieter Erath; Peter Bramlage; Stefanie Lanzinger
Journal:  BMJ Open Diabetes Res Care       Date:  2021-06

4.  Lean diabetes in middle-aged adults: A joint analysis of the German DIVE and DPV registries.

Authors:  Bettina Hartmann; Stefanie Lanzinger; Peter Bramlage; Felix Groß; Thomas Danne; Siegfried Wagner; Dietmar Krakow; Artur Zimmermann; Christian Malcharzik; Reinhard W Holl
Journal:  PLoS One       Date:  2017-08-21       Impact factor: 3.240

5.  The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany.

Authors:  Peter Bramlage; Sascha R Tittel; Christian Wagner; Kerstin König; Dirk Raddatz; Rosmarie Weber-Lauffer; Diether Erath; Jost Hilgenberg; Carsten Spies; Thomas Danne; Maximilian Gabler; Johannes Foersch; Ludwin Ley; Jochen Seufert
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

6.  Renal function deterioration in adult patients with type-2 diabetes.

Authors:  Peter Bramlage; Stefanie Lanzinger; Eva Hess; Simon Fahrner; Christoph H J Heyer; Mathias Friebe; Ivo Buschmann; Thomas Danne; Reinhard W Holl; Jochen Seufert
Journal:  BMC Nephrol       Date:  2020-07-29       Impact factor: 2.388

7.  Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases.

Authors:  Gesine van Mark; Stefanie Lanzinger; Ralf Barion; Michael Degenhardt; Simone Badis; Horst Noll; Thomas Danne; Peter Bramlage; Jochen Seufert; Reinhard W Holl
Journal:  Ther Adv Endocrinol Metab       Date:  2019-02-28       Impact factor: 3.565

8.  DPARD: rationale, design and initial results from the Dutch national diabetes registry.

Authors:  Jessica C G Bak; Dick Mul; Erik H Serné; Harold W de Valk; Theo C J Sas; Petronella H Geelhoed-Duijvestijn; Mark H H Kramer; Max Nieuwdorp; Carianne L Verheugt
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

9.  Treatment intensification using long-acting insulin -predictors of future basal insulin supported oral therapy in the DIVE registry.

Authors:  Thomas Danne; Tobias Bluhmki; Jochen Seufert; Matthias Kaltheuner; Wolfgang Rathmann; Jan Beyersmann; Peter Bramlage
Journal:  BMC Endocr Disord       Date:  2015-10-07       Impact factor: 2.763

10.  Type 2 diabetes in older patients: an analysis of the DPV and DIVE databases.

Authors:  Gesine van Mark; Sascha R Tittel; Stefan Sziegoleit; Franz Josef Putz; Mesut Durmaz; Michaela Bortscheller; Ivo Buschmann; Jochen Seufert; Reinhard W Holl; Peter Bramlage
Journal:  Ther Adv Endocrinol Metab       Date:  2020-09-20       Impact factor: 3.565

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.